ProKidney (PROK)
US Market

ProKidney (PROK) Financial Statements


ProKidney Financial Overview

ProKidney's market cap is currently ―. The company's EPS TTM is $-0.495; its P/E ratio is -23.67; ProKidney is scheduled to report earnings on March 28, 2023, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 0.00-$ 0.00$ 0.00-
Gross Profit-----
EBIT$ -4.01M-$ -255.53K$ -143.00-
EBITDA$ -4.01M-$ -255.53K$ -143.00-
Net Income Common Stockholders$ -3.98M-$ -252.49K$ -143.00-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.89K$ 440.49K$ 542.30K$ 223.54K$ 0.00
Total Assets$ 250.75M$ 251.20M$ 251.44M$ 622.80K$ 25.12K
Total Debt$ 0.00$ 0.00$ 0.00$ 300.00K$ 255.00
Net Debt$ -51.89K$ -440.49K$ -542.30K$ 76.46K$ 255.00
Total Liabilities$ 13.11M$ 9.58M$ 7.76M$ 603.13K$ 5.30K
Stockholders Equity$ 237.64M$ 241.62M$ 243.69M$ 19.68K$ 19.82K
Cash Flow-
Free Cash Flow$ -388.60K----
Operating Cash Flow$ -388.60K----
Investing Cash Flow-----
Financing Cash Flow$ 0.00----
Currency in USD

ProKidney Earnings and Revenue History

ProKidney Debt to Assets

ProKidney Cash Flow

ProKidney Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis